Xtant Medical Holdings, Inc.

XTNT

Xtant Medical Holdings, Inc.

XTNT

Insider Sentiment (TTM):

Last Purchase:2023-11-17Last Sale:2025-04-10Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:80,555,884Shares Outstanding:140,058,787Institutional Ownership Pct.:57.52%

Earnings Market Reaction:

Filing Date:2026-08-11Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Assets Current
Cash And Cash Equivalents At Carrying Value	10	12	17	10	7	5	6	7	5	5	6	9
Restricted Cash Current	0	0	0	0	0	0	0	0	0	0	0	0
Accounts Receivable Net Current	19	17	18	26	27	23	21	21	21	21	21	19
Inventory Net	33	32	30	41	40	39	39	42	41	39	37	34
Notes And Loans Receivable Net Current	-	-	10	-	-	-	-	-	-	-	-	-
Prepaid Expense And Other Assets Current	2	1	2	1	1	1	2	2	2	2	1	2
Assets Current	65	63	78	78	76	69	67	71	69	67	65	64
Property Plant And Equipment Net	6	6	6	10	10	11	10	10	9	9	9	9
Operating Lease Right Of Use Asset	3	3	3	4	3	1	1	1	1	1	2	2
Goodwill	6	6	6	7	7	7	7	7	7	7	7	7
Intangible Assets Net Excluding Goodwill	0	0	0	7	7	8	8	9	9	10	10	10
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	80	78	94	106	103	96	94	99	96	94	93	92
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	6	5	4	7	7	7	8	8	7	7	7	5
Accrued Liabilities Current	7	8	11	12	11	10	8	9	9	10	10	9
Long Term Debt Current	4	4	4	-	-	-	-	3	-	-	-	3
Operating Lease Liability Current	1	1	1	1	1	1	1	1	1	1	1	1
Finance Lease Liability Current	-	0	0	0	0	0	0	0	0	0	0	0
Lines Of Credit Current	12	0	11	11	12	11	12	13	12	10	5	4
Liabilities Current	30	19	29	36	31	30	29	34	28	28	23	22
Liabilities Noncurrent
Operating Lease Liability Noncurrent	2	3	3	3	2	0	0	0	0	1	1	1
Finance Lease Liability Noncurrent	-	0	0	0	0	0	0	0	0	0	0	0
Long Term Debt Noncurrent	7	8	11	17	22	22	22	19	22	17	17	14
Other Liabilities	-	-	-	0	0	0	-	-	-	-	-	-
Deferred Income Tax Liabilities Net	-	-	0	-	-	-	0	-	-	-	0	-
Other Liabilities Noncurrent	0	0	-	-	-	-	-	0	0	0	-	-
Liabilities	40	29	43	56	55	52	51	53	51	46	41	37
Stockholders Equity
Additional Paid In Capital	307	306	305	305	304	303	303	302	296	295	294	294
Accumulated Other Comprehensive Income Loss Net Of…	-0	-0	-	0	0	-0	-0	0	-0	-0	0	-0
Retained Earnings Accumulated Deficit	-267	-258	-254	-255	-256	-259	-259	-256	-251	-247	-243	-239
Stockholders Equity	40	49	51	50	49	44	43	46	45	48	51	55
Liabilities And Stockholders Equity	80	78	94	106	103	96	94	99	96	94	93	92
Allowance For Doubtful Accounts Receivable Current	-	-	-	-	-	-	-	1	1	1	1	1
Accounts And Financing Receivable Allowance For Cr…	-	2	2	2	2	2	1	-	-	-	1	-
Preferred Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Shares Authorized	300	300	300	300	300	300	300	300	300	300	300	300
Common Stock Shares Issued	140	140	140	140	139	139	139	139	130	130	130	130
Shares Outstanding	140	140	140	140	139	139	139	139	130	130	130	130

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-4.17%	-14.58%	-10.42%	-	-	-	-	-	-	-	-	-
2025	34.62%	32.69%	7.69%	-5.97%	-2.99%	31.34%	-18.42%	-1.32%	-22.37%	-7.14%	-14.29%	-21.43%
2024	-8.86%	-16.46%	-15.19%	13.85%	3.08%	-16.92%	-25.93%	-1.85%	12.96%	2.08%	6.25%	54.17%
2023	-	-	-	-	-	-	10.43%	3.48%	-6.96%	-7.77%	-27.18%	-33.98%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	2.16	3.34	2.65	2.21	2.47	2.34	2.35	2.12	2.44	2.34	2.82	2.92
Quick Ratio	0.99	1.56	1.55	1.02	1.11	0.98	0.94	0.82	0.94	0.92	1.16	1.27
Working Capital	34.81M	43.85M	48.76M	42.83M	44.99M	39.56M	38.54M	37.74M	40.66M	38.10M	41.88M	42.19M
Leverage & Debt
Debt to Equity	0.99	0.60	0.85	1.11	1.13	1.18	1.18	1.16	1.12	0.97	0.80	0.68
Interest Coverage TTM	-3.80	1.02	1.98	1.55	0.01	-1.73	-2.90	-3.64	-4.00	-3.77	-3.46	-3.09
Debt Ratio	0.50	0.38	0.46	0.53	0.53	0.54	0.54	0.54	0.53	0.49	0.45	0.41
Efficiency & Turnover
Asset Turnover TTM	1.20	1.40	1.42	1.30	1.28	1.29	1.26	1.19	1.38	1.29	1.19	1.06
Days Sales Outstanding TTM	77.26	60.86	52.41	63.17	68.76	67.09	64.42	63.62	57.46	60.19	63.13	67.42
Receivables Turnover TTM	4.72	6.00	6.96	5.78	5.31	5.44	5.67	5.74	6.35	6.06	5.78	5.41
Per Share Metrics
Diluted EPS TTM	-0.08	0.01	0.03	0.01	-0.03	-0.08	-0.12	-0.13	-0.03	-0.01	0.01	0.02
Free Cash Flow Per Share TTM	-0.00	0.06	0.07	0.04	-0.02	-0.07	-0.12	-0.13	-0.13	-0.11	-0.09	-0.10
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Margin Metrics
Gross Profit Margin TTM	59.39%	62.34%	62.92%	62.02%	60.16%	58.18%	58.17%	60.89%	61.61%	61.48%	60.75%	59.44%
Operating Profit Margin TTM	-9.58%	2.71%	5.44%	4.77%	0.02%	-6.17%	-10.30%	-12.29%	-12.26%	-11.91%	-11.13%	-10.29%
Net Profit Margin TTM	-10.17%	1.50%	3.71%	1.32%	-3.58%	-9.80%	-14.03%	-15.45%	-3.00%	-1.64%	0.72%	3.51%
Growth Metrics
Net Revenue Growth (1Y)	-14.28%	-0.32%	14.21%	16.88%	15.16%	20.81%	28.44%	45.11%	63.37%	60.81%	57.50%	38.47%
Net Income Growth (1Y)	143.17%	-115.23%	-130.23%	-109.96%	37.41%	621.48%	-2,592.27%	-738.63%	-62.25%	-80.10%	-107.78%	-132.18%
EPS Growth (1Y)	141.52%	-115.12%	-128.96%	-109.63%	28.50%	575.48%	-2,320.58%	-705.73%	-68.45%	-83.35%	-106.15%	-123.42%
Valuation Metrics
P/E TTM	-5.29	42.95	21.89	51.83	-22.51	-5.45	-3.58	-5.22	-24.62	-91.66	203.90	51.18
P/B TTM	1.47	1.61	2.14	1.80	2.13	1.49	1.37	2.01	1.82	3.19	2.62	2.58
P/S TTM	0.54	0.64	0.81	0.68	0.81	0.53	0.50	0.81	0.74	1.50	1.47	1.80
Market Cap	58.91M	78.43M	108.83M	90.81M	103.09M	65.36M	58.81M	91.87M	82.07M	152.34M	134.58M	140.95M
Enterprise Value	71.68M	78.59M	116.92M	108.93M	130.50M	93.82M	86.84M	119.63M	110.43M	174.87M	150.71M	153.45M
Calculated Values
Free Cash Flow TTM	-696.00K	7.77M	10.16M	5.17M	-2.83M	-9.39M	-16.01M	-17.28M	-17.52M	-14.80M	-10.97M	-12.42M
Net Debt	12.78M	154.00K	8.09M	18.12M	27.41M	28.46M	28.03M	27.76M	28.36M	22.54M	16.14M	12.50M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-04-10Sale

Owner: Orbimed, Rof Ii Llc, Orbi…

Title: -

Shares: 73,114,592

Price/Share: $0.42

Value: $30,708,128.64

Shares Owned: -

Relationship: TenPercentOwner

Ownership: Indirect

2023-11-17Purchase

Owner: Brandt, Kevin D

Title: Chief Commercial Officer

Shares: 41,670

Price/Share: $1.20

Value: $50,004.00

Shares Owned: 815,860

Relationship: Officer

Ownership: Direct

2023-01-18Sale

Owner: Neils, Scott C

Title: Chief Financial Officer

Shares: 8,673

Price/Share: $0.61

Value: $5,290.53

Shares Owned: 403,960

Relationship: Officer

Ownership: Direct

2022-10-19Sale

Owner: Browne, Sean E

Title: President and CEO

Shares: 51,100

Price/Share: $0.62

Value: $31,682.00

Shares Owned: 1,506,584

Relationship: Director,Officer

Ownership: Direct

2022-10-07Purchase

Owner: Vizirgianakis, Stavros G.

Title: -

Shares: 2,264,861

Price/Share: $0.48

Value: $1,087,133.28

Shares Owned: 5,850,716

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-04-10	Orbimed, Rof Ii Llc, Orbi…	TenPercentOwner	-	Indirect	Sale	73,114,592	0.42	$30,708,128.64	0	4
2023-11-17	Brandt, Kevin D	Officer	Chief Commercial Officer	Direct	Purchase	41,670	1.20	$50,004.00	815,860	4
2023-01-18	Neils, Scott C	Officer	Chief Financial Officer	Direct	Sale	8,673	0.61	$5,290.53	403,960	4
2022-10-19	Browne, Sean E	Director,Officer	President and CEO	Direct	Sale	51,100	0.62	$31,682.00	1,506,584	4
2022-10-07	Vizirgianakis, Stavros G.	Director	-	Direct	Purchase	2,264,861	0.48	$1,087,133.28	5,850,716	4
2022-08-17	Brandt, Kevin D	Officer	Chief Commercial Officer	Direct	Sale	4,300	0.48	$2,064.00	703,571	4
2022-08-17	Neils, Scott C	Officer	Chief Financial Officer	Direct	Sale	1,270	0.48	$609.60	412,633	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

57.52%

Inst. Shares: 80,555,884

Shares Outstanding: 140,058,787

2025-12-31

58.19%

Inst. Shares: 81,190,747

Shares Outstanding: 139,531,791

2025-09-30

57.25%

Inst. Shares: 79,992,259

Shares Outstanding: 139,712,969

2025-06-30

57.39%

Inst. Shares: 79,946,321

Shares Outstanding: 139,310,589

2025-03-31

69.25%

Inst. Shares: 96,310,547

Shares Outstanding: 139,068,831

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	80,555,884	140,058,787	57.52%
2025-12-31	81,190,747	139,531,791	58.19%
2025-09-30	79,992,259	139,712,969	57.25%
2025-06-30	79,946,321	139,310,589	57.39%
2025-03-31	96,310,547	139,068,831	69.25%
2024-12-31	96,638,606	133,665,075	72.30%
2024-09-30	98,215,049	135,100,233	72.70%
2024-06-30	90,066,893	130,269,710	69.14%
2024-03-31	89,596,974	130,201,251	68.81%
2023-12-31	89,418,866	119,093,687	75.08%
2023-09-30	89,607,029	128,140,238	69.93%
2023-06-30	81,168,877	108,897,048	74.54%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Xtant Medical Holdings, Inc. (XTNT) — SEC Financial Statements & Analysis

Xtant Medical Holdings, Inc. (XTNT) is a surgical & medical instruments & apparatus company, incorporated in DE. Xtant Medical Holdings, Inc. trades on NYSE as: XTNT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Xtant Medical Holdings, Inc. reported a -14.28% year-over-year revenue growth, a Gross Profit Margin of 59.39% (TTM), a Debt-to-Equity ratio of 0.99x, a Price-to-Sales (P/S) ratio of 0.54x (TTM), a Price-to-Book (P/B) ratio of 1.47x (TTM), at a market cap of $58.91M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -14.28%
Gross Profit Margin TTM: 59.39%
Debt To Equity: 0.99x
P/S TTM: 0.54x
P/B TTM: 1.47x
Market Cap: $58.91M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Xtant Medical Holdings, Inc. in?

Xtant Medical Holdings, Inc. (XTNT) operates in the Surgical & Medical Instruments & Apparatus industry.

What is XTNT's market cap?

Xtant Medical Holdings, Inc. (XTNT) has a market capitalization of $58.91M as of 2026-06-30.

What exchange does XTNT trade on?

Xtant Medical Holdings, Inc. (XTNT) trades on the NYSE.

Where is Xtant Medical Holdings, Inc. incorporated?

Xtant Medical Holdings, Inc. is incorporated in DE.